Free Delivery Over $100
|
|
|||
|
||||
OverviewThe book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice. Full Product DetailsAuthor: Karin BosshardPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer Gabler Edition: 1st ed. 2018 Weight: 5.743kg ISBN: 9783658220730ISBN 10: 3658220732 Pages: 411 Publication Date: 24 May 2018 Audience: College/higher education , Postgraduate, Research & Scholarly Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsOverview of terminologies used in the context of personalized medicine.- Description of personalized medicine’s impact on the healthcare landscape.- Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice.- Analysis of institutional barriers to the translation of personalized medicine in Switzerland.- Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice.ReviewsAuthor InformationDr. Karin Bosshard wrote this book during her time with a globally leading management consultancy where she was working as a strategy consultant. The author is currently working at an international pharmaceutical and diagnostics company and is a lecturer at the University of St. Gallen. Tab Content 6Author Website:Countries AvailableAll regions |
||||
